Combination of vatalanib and a 20-HETE synthesis inhibitor results in decreased tumor growth in an animal model of human glioma.

Onco Targets Ther · 2016 · PMC4790509 · PMID 27022280

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

In both early and late HET0016 treatment groups, MMP-9 was lower (borderline significant differences) compared with vehicle-treated animals.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.